Virucidal efficacy of a range of commercially available proprietary personal care formulations tested against selected SARS-CoV-2 variants of concern (VOC) at user relevant dilutions and contact duration.
收藏数据链接：
官方服务：
资源简介：
TCID50, 50% tissue culture infective dose.
创建时间：
2022-02-24
